# Extendicare

## PROCEDURE

**MANUAL:** Infection Prevention and Control
**INDEX:** IPC6-P10.03
**SECTION:** Multi-Drug-Resistant Organisms (MDROs)
**DESCRIPTION:** Vancomycin-Resistant Enterococci (VRE)
**APPROVED BY:** Chief Medical Officer
**EFFECTIVE DATE:** February 18, 2025
**REVIEWED DATE:** February 11, 2025
**MODIFIED DATE:** May 30, 2025

----

## POLICY

### Multi-Drug-Resistant Organisms (MDROs)

## PROCEDURE

### Screening
- The MDRO Screening Tool will be completed within 24 hours of admission or readmission from hospital where stay was greater than 12 hours.
- If warranted by the MDRO Assessment or per health authority requirements, complete surveillance screening for VRE.
- Screening includes:
- A stool specimen or rectal swab (stained with feces)
- Laboratory results will be recorded in the health care record and HealthConnex (if applicable).

### Management
- Decolonization is not effective and is not recommended.
- For a VRE infection, implement contact precautions and as per health authority guidelines.
- For a VRE colonization, implement contact precautions for direct care.
- Follow Testing for Multi-Drug-Resistant-Organism Algorithm for surveillance testing.

#### Retirement Specific:
- If VRE is identified, it will be noted on the plan of care. Appropriate precautions will remain in place until it is cleared, or the resident moves out.

#### Alberta and Manitoba Specific:
- Admission and clearance testing for VRE is not recommended.
- Maintain routine practices, implement additional precautions if required based on risk assessment.

## EDUCATION
1. IPC6-P10-E1 - MDRO Guide

----

Helping people live better

This document is uncontrolled when printed.
Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025

----

Page 1 of 2

# PROCEDURE

## SECTION: Multi-Drug-Resistant Organisms (MDROs)

### DESCRIPTION: Vancomycin-Resistant Enterococci (VRE)

### INDEX: IPC6-P10.03

#### TOOLS
1. IPC6-P10-T1 – MDRO Screening
2. IPC6-P10-T2 – MDRO Risk Assessment

----

Helping people live better

> This document is uncontrolled when printed.
> Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025

----

**Page 2 of 2**